591 related articles for article (PubMed ID: 32328061)
1. The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
Amoriello R; Greiff V; Aldinucci A; Bonechi E; Carnasciali A; Peruzzi B; Repice AM; Mariottini A; Saccardi R; Mazzanti B; Massacesi L; Ballerini C
Front Immunol; 2020; 11():559. PubMed ID: 32328061
[TBL] [Abstract][Full Text] [Related]
2. Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis.
Harris KM; Lim N; Lindau P; Robins H; Griffith LM; Nash RA; Turka LA; Muraro PA
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877116
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
[TBL] [Abstract][Full Text] [Related]
4. Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I
Front Immunol; 2022; 13():798300. PubMed ID: 35197974
[TBL] [Abstract][Full Text] [Related]
5. T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
Muraro PA; Robins H; Malhotra S; Howell M; Phippard D; Desmarais C; de Paula Alves Sousa A; Griffith LM; Lim N; Nash RA; Turka LA
J Clin Invest; 2014 Mar; 124(3):1168-72. PubMed ID: 24531550
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis.
Mariottini A; Innocenti C; Forci B; Magnani E; Mechi C; Barilaro A; Nistri R; Fani A; Saccardi R; Massacesi L; Repice AM
Eur J Neurol; 2019 Apr; 26(4):624-630. PubMed ID: 30414315
[TBL] [Abstract][Full Text] [Related]
7. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA
Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
[TBL] [Abstract][Full Text] [Related]
8. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.
Duszczyszyn DA; Beck JD; Antel J; Bar-Or A; Lapierre Y; Gadag V; Haegert DG
Clin Exp Immunol; 2006 Feb; 143(2):305-13. PubMed ID: 16412055
[TBL] [Abstract][Full Text] [Related]
9. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
10. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
Arruda LCM; de Azevedo JTC; de Oliveira GLV; Scortegagna GT; Rodrigues ES; Palma PVB; Brum DG; Guerreiro CT; Marques VD; Barreira AA; Covas DT; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KCR
Clin Immunol; 2016 Aug; 169():47-57. PubMed ID: 27318116
[TBL] [Abstract][Full Text] [Related]
11. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF
J Neurol Neurosurg Psychiatry; 2019 May; 90(5):514-521. PubMed ID: 30538138
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
Front Immunol; 2018; 9():834. PubMed ID: 29867923
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.
Boziki MK; Karapanayotides T; Papadopoulos G; Lagoudaki R; Melo P; Bakirtzis C; Nikolaidis I; Gounari E; Tsavdaridou V; Skoura L; Afrantou T; Tatsi T; Grigoriadou E; Polyzoidou E; Mandoras N; Giantzi V; Kalogera-Fountzila A; Ioannidis P; Parissis D; Pelidou SH; Zoidou S; Grigoriadis N
Neurol Res; 2020 Mar; 42(3):209-221. PubMed ID: 32048570
[No Abstract] [Full Text] [Related]
14. Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
Harris KM; Lu T; Lim N; Turka LA
Front Immunol; 2018; 9():100. PubMed ID: 29456529
[TBL] [Abstract][Full Text] [Related]
15. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.
Lossius A; Johansen JN; Vartdal F; Robins H; Jūratė Šaltytė B; Holmøy T; Olweus J
Eur J Immunol; 2014 Nov; 44(11):3439-52. PubMed ID: 25103993
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis.
Biegler BW; Yan SX; Ortega SB; Tennakoon DK; Racke MK; Karandikar NJ
J Neuroimmunol; 2006 Nov; 180(1-2):159-71. PubMed ID: 16935352
[TBL] [Abstract][Full Text] [Related]
17. High-throughput sequencing reveals restricted TCR Vβ usage and public TCRβ clonotypes among pancreatic lymph node memory CD4(+) T cells and their involvement in autoimmune diabetes.
Marrero I; Aguilera C; Hamm DE; Quinn A; Kumar V
Mol Immunol; 2016 Jun; 74():82-95. PubMed ID: 27161799
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires.
Gil A; Kamga L; Chirravuri-Venkata R; Aslan N; Clark F; Ghersi D; Luzuriaga K; Selin LK
mBio; 2020 Mar; 11(2):. PubMed ID: 32184241
[TBL] [Abstract][Full Text] [Related]
19. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
[TBL] [Abstract][Full Text] [Related]
20. TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood.
Amoriello R; Chernigovskaya M; Greiff V; Carnasciali A; Massacesi L; Barilaro A; Repice AM; Biagioli T; Aldinucci A; Muraro PA; Laplaud DA; Lossius A; Ballerini C
EBioMedicine; 2021 Jun; 68():103429. PubMed ID: 34127432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
